AU2001249193A1 - Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use - Google Patents

Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use

Info

Publication number
AU2001249193A1
AU2001249193A1 AU2001249193A AU4919301A AU2001249193A1 AU 2001249193 A1 AU2001249193 A1 AU 2001249193A1 AU 2001249193 A AU2001249193 A AU 2001249193A AU 4919301 A AU4919301 A AU 4919301A AU 2001249193 A1 AU2001249193 A1 AU 2001249193A1
Authority
AU
Australia
Prior art keywords
myo
estrogen
regulated
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001249193A
Other languages
English (en)
Inventor
Alan R. Brooks
Gary G. Deng
Gabor M. Rubanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2001249193A1 publication Critical patent/AU2001249193A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001249193A 2000-03-10 2001-03-12 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use Abandoned AU2001249193A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18830600P 2000-03-10 2000-03-10
US60/188,306 2000-03-10
US80237301A 2001-03-09 2001-03-09
US09/802,373 2001-03-09
PCT/US2001/008147 WO2001068880A2 (fr) 2000-03-10 2001-03-12 Meso-inositol phosphate synthase regulee par estrogenes : compositions et methodes d'utilisation

Publications (1)

Publication Number Publication Date
AU2001249193A1 true AU2001249193A1 (en) 2001-09-24

Family

ID=26883944

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001249193A Abandoned AU2001249193A1 (en) 2000-03-10 2001-03-12 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use

Country Status (5)

Country Link
EP (1) EP1268820A2 (fr)
JP (1) JP2003526375A (fr)
AU (1) AU2001249193A1 (fr)
NO (1) NO20024298L (fr)
WO (1) WO2001068880A2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1074617A3 (fr) * 1999-07-29 2004-04-21 Research Association for Biotechnology Amorces pour la synthèse de cADN de pleine longueur et leur utilisation

Also Published As

Publication number Publication date
NO20024298D0 (no) 2002-09-09
JP2003526375A (ja) 2003-09-09
EP1268820A2 (fr) 2003-01-02
WO2001068880A2 (fr) 2001-09-20
NO20024298L (no) 2002-10-30
WO2001068880A3 (fr) 2002-04-25
WO2001068880A9 (fr) 2003-01-16

Similar Documents

Publication Publication Date Title
AU2778801A (en) Antisense compositions and methods
AU2001280922A1 (en) Bioactive coating compositions and methods
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001279202A1 (en) Compositions containing phosphate and xanthan gum variants
AU2001239947A1 (en) Methods and compositions for regulating adipocytes
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2001234437A1 (en) Deicing compositions and methods of use
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2001253255A1 (en) Compositions and methods for inhibiting gene expression
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2001288976A1 (en) Compositions and methods of use for extracts of rutaceae plants
AU2002367903A1 (en) Biologic-chemical herbicide compositions and methods of use
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2001293048A1 (en) Antiviral compositions and methods of use
AU2002251801A1 (en) Composition containing hedychium extract and use thereof
AU2002239258A1 (en) Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon
AU2001290678A1 (en) Alginate particle formulation
AU2002223544A1 (en) Distribution of content
AU2002222148A1 (en) Preparation of spheroids
AU2001255801A1 (en) Neutralization of phosphate esters, compositions based upon and methods using same
AU2001266124A1 (en) 2-aminothiazoline derivatives and their use as no-synthase inhibitors
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2003212724A1 (en) Composition comprising phosphate
AU2002351200A1 (en) Compositions and methods for inhibiting prenyltransferases